Skip to content
The Policy VaultThe Policy Vault

FylnetraCigna

Peripheral Blood Progenitor Cell Transplantation (PBPC) in Patients with Cancer

Initial criteria

  • Approve one dose if prescribed by or in consultation with an oncologist, a hematologist, or a physician who specializes in transplantation.

Approval duration

one dose